QuVa Pharma, Inc.
FDA inspection history in Sugar Land, Texas, 2016 to 2026
- 7
- Form 483s
- 1
- Untitled letter
Every document, by year
- Form 483
- Untitled letter
2016: one amended 483; 2017: one Form 483; 2019: one Form 483; 2020: one Form 483; 2022: one Form 483; 2024: one Form 483; 2025: one untitled letter; 2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2016–26Six Form 483s, one amended 483 and one untitled letter, at Sugar Land, Texas.
- 2019The longest 483 on file: 6 observations over 4 pages at Sugar Land, Texas.
Cited most
Across all QuVa Pharma observations on file
- 21 CFR 211.192Production record review7
- 21 CFR 211.113Control of microbiological contamination6
- 21 CFR 211.42Design and construction features4
- 21 CFR 211.100(a)Written procedures; deviations1
- 21 CFR 211.160(b)(3)General requirements1
The complete QuVa Pharma file.
All 8 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
15% off buying them one by one
Sites
Sugar Land, Texas
Six Form 483s, one untitled letter and one amended 483 · 2016 to 2026 · 27 observations
Latest: Form 483, May 4, 2026 →
Documents
8 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-05-04 | 483 Form 483 | Sugar Land, Texas | 3 | $99 |
| 2025-06-18 | Untitled letter Untitled letter | Sugar Land, Texas | — | $99 |
| 2024-10-28 | 483 Form 483 | Sugar Land, Texas | 4 | $99 |
| 2022-08-18 | 483 Form 483 | Sugar Land, Texas | 3 | $99 |
| 2020-02-05 | 483 Form 483 | Sugar Land, Texas | 5 | $99 |
| 2019-04-23 | 483 Form 483 | Sugar Land, Texas | 6 | $99 |
| 2017-06-02 | 483 Form 483 | Sugar Land, Texas | 1 | $99 |
| 2016-03-12 | Amended 483 Amended 483 | Sugar Land, Texas | 5 | $99 |
Investigators on these documents
Camerson E. Moore (4)Darla J. Christopher (2)Stephen D. Brown (2)Jason R. Caballero (1)Shatina R. Alridge (1)
FEI number 3012053582 · most recent document May 4, 2026
About QuVa Pharma, Inc.
How many FDA Form 483s has QuVa Pharma, Inc. received?
FDA Intel has 7 Form 483s on file for QuVa Pharma, Inc.; the most recent is dated May 4, 2026.
When was QuVa Pharma, Inc. last inspected by FDA?
The most recent FDA inspection document on file for QuVa Pharma, Inc. is a Form 483 dated May 4, 2026, for the site in Sugar Land, Texas.
What did FDA cite at QuVa Pharma, Inc.?
The regulations cited most in the observations on file for QuVa Pharma, Inc. are 21 CFR 211.192 (Production record review), 7 times; 21 CFR 211.113 (Control of microbiological contamination), 6 times; 21 CFR 211.42 (Design and construction features), 4 times.
Has QuVa Pharma, Inc. received an FDA untitled letter?
Yes. FDA Intel has 1 FDA untitled letter on file for QuVa Pharma, Inc.; the most recent is dated Jun 18, 2025. An untitled letter is FDA's enforcement letter for violations that don't rise to warning-letter level.